About Hospital Universitari de Bellvitge ; Servicio de Neumologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hospital Universitari de Bellvitge ; Servicio de Neumologia
During the past decade, Hospital Universitari de Bellvitge ; Servicio de Neumologia conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on
average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
2009-03-25
2012-10-18
Terminated
105
Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
2010-08-01
2013-10-01
Completed
800
Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
2011-02-01
2014-02-01
Completed
799
Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women
2012-10-24
2018-09-06
Completed
583
Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
2013-03-12
2018-10-03
Completed
872
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hospital Universitari de Bellvitge ; Servicio de Neumologia
According to Clinical.Site data, the most researched conditions in "Hospital Universitari de Bellvitge ; Servicio de Neumologia" are
"Idiopathic Pulmonary Fibrosis" (3 trials) and "Lung Diseases, Interstitial" (1 trials). Many other conditions were trialed in "Hospital Universitari de Bellvitge ; Servicio de Neumologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitari de Bellvitge ; Servicio de Neumologia
Most popular intervention types in "Hospital Universitari de Bellvitge ; Servicio de Neumologia" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Pirfenidone" (4 trials), "Placebo" (3 trials), "Lebrikizumab" (1 trials), "Nintedanib" (1 trials) and "Sildenafil" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitari de Bellvitge ; Servicio de Neumologia
The vast majority of trials in "Hospital Universitari de Bellvitge ; Servicio de Neumologia" are
4 trials for "All" genders.
Clinical Trials Status at Hospital Universitari de Bellvitge ; Servicio de Neumologia
Currently, there are NaN active trials in "Hospital Universitari de Bellvitge ; Servicio de Neumologia".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Hospital Universitari de Bellvitge ; Servicio de Neumologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitari de Bellvitge ; Servicio de Neumologia, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".